SeqLL Enters 2 Year CRADA with the FBI

by Ben

February 7, 2023

Biopharmaceutical

Palisade Bio keeps Running

December 30, 2022

Biopharmaceutical

Viking Therapeutics Hits new 52-Week High on positive Madrigal Pharmaceuticals data

December 19, 2022

Biopharmaceutical

Shuttle Pharmaceuticals continues recent Move Higher

December 5, 2022

Home Category Market News

Market News

Biopharmaceutical

FDA Approves Rigel’s REZLIDHI (olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation

by Ben

December 2, 2022

(24/7 MARKET NEWS) – Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced, after yesterday’s market close, that the FDAs approved REZLIDHIA (olutasidenib)...

Biopharmaceutical

VIVO System Used in More Than 800 Procedures in U.S. and European Hospitals

by Ben

December 1, 2022

(24/7 MARKET NEWS) – Catheter Precision, Inc. announced, this morning, that more than 800 procedures, utilizing the VIVO System that...

Biopharmaceutical

Creative Medical Technology Announces FDA Clearance of Investigational New Drug Application

by Ben

November 3, 2022

(24/7 MARKET NEWS) – Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) announced, this morning, that the FDA cleared the Company's...

SeqLL Enters 2 Year CRADA with the FBI

Palisade Bio keeps Running

Viking Therapeutics Hits new 52-Week High on positive Madrigal Pharmaceuticals data

Shuttle Pharmaceuticals continues recent Move Higher

Market News

FDA Approves Rigel’s REZLIDHI (olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation

VIVO System Used in More Than 800 Procedures in U.S. and European Hospitals

Creative Medical Technology Announces FDA Clearance of Investigational New Drug Application

Add New Playlist